top of page
Search


AAB Calls For Inclusion of Biotech Provisions in the FY26 National Defense Authorization Act (NDAA)
The AAB joined with 32 other leaders in the U.S. biomanufacturing sector calling for the inclusion of the biotechnology provisions in the Fiscal Year 2026 National Defense Authorization Act (NDAA). The letter notes that the National Security Commission on Emerging Biotechnology (NSCEB) concluded that: "Advances in biotechnology represent a paradigm shift in how conflicts can be fought and won. The countries that seize the moment will retain or achieve superpower status. Those
Oct 27, 20251 min read


Young, Padilla Introduce Legislative Package to Advance American Biomanufacturing and Biotechnology
On September 3, 2025, U.S. Senators Todd Young (R-Ind.), Chairman of the National Security Commission on Emerging Biotechnology ( NSCEB )...
Sep 10, 20251 min read


AI+ Biotechnology Summit marks the release of NSCEB Final Report
The Special Competitive Studies Project hosted the AI+ Biotechnology Summit today, marking the release of the National Security...
Apr 9, 20251 min read


National Security Commission on Emerging Biotechnology Releases Final Report
Washington, DC – Today, the National Security Commission on Emerging Biotechnology (NSCEB) delivered its final report and action plan to...
Apr 7, 20251 min read


Report: U.S. Industrial Bioeconomy Supports Nearly 644,000 Jobs
Biomanufacturing advocates today released a new report that provides a closer look at the employment, wages, and economic activity...
Jun 10, 20242 min read


Report: Breaking the Cost Barrier on Biomanufacturing
A new report from AAB member Synonym (and The Boston Consulting Group) lays out the roadmap to biomanufacturing ‘moment' and predicts the...
Feb 15, 20241 min read
bottom of page
